Drug Shortage Report for APO-PRAZO TAB 2MG

Last updated on 2025-03-12 History
Report ID 188943
Drug Identification Number 00882828
Brand name APO-PRAZO TAB 2MG
Common or Proper name PRAZOSIN
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) PRAZOSIN
Strength(s) 2MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100 BTL
ATC code C02CA
ATC description ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-04-04
Estimated end date
Actual end date 2025-01-24
Shortage status Resolved
Updated date 2025-03-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2025-03-12 English Compare
v15 2025-01-28 French Compare
v14 2025-01-28 English Compare
v13 2024-11-08 French Compare
v12 2024-11-08 English Compare
v11 2024-09-25 French Compare
v10 2024-09-25 English Compare
v9 2024-06-12 French Compare
v8 2024-06-12 English Compare
v7 2024-03-27 French Compare
v6 2024-03-27 English Compare
v5 2023-12-13 French Compare
v4 2023-12-13 English Compare
v3 2023-05-23 English Compare
v2 2023-04-06 French Compare
v1 2023-04-06 English Compare

Showing 1 to 16 of 16